| Record ID | ia:regulationofphar0000grab |
| Source | Internet Archive |
| Download MARC XML | https://archive.org/download/regulationofphar0000grab/regulationofphar0000grab_marc.xml |
| Download MARC binary | https://www.archive.org/download/regulationofphar0000grab/regulationofphar0000grab_meta.mrc |
LEADER: 01252cam a2200337 a 4500
001 83002648
003 DLC
005 20010320123600.0
008 830125s1983 dcua b 000 0 eng
010 $a 83002648
020 $a0844735175 (pbk.)
040 $aDLC$cDLC$dDLC
043 $an-us---
050 00 $aKF3885$b.G7 1983
060 $aQV 771 G728F
082 00 $a344.73/04233$a347.3044233$219
100 1 $aGrabowski, Henry G.
245 14 $aThe regulation of pharmaceuticals :$bbalancing the benefits and risks /$cHenry G. Grabowski, John M. Vernon.
260 $aWashington :$bAmerican Enterprise Institute for Public Policy Research,$cc1983.
300 $a74 p. :$bill. ;$c23 cm.
440 0 $aAEI studies ;$v377
504 $aInludes bibliographical references.
650 0 $aDrugs$xLaw and legislation$zUnited States.
650 0 $aPharmacy$xLaw and legislation$zUnited States.
610 10 $aUnited States.$bFood and Drug Administration.
650 2 $aDrug industry$xStandards$zUnited States.
650 2 $aDrugs$xStandards.
650 2 $aLegislation, Drug$zUnited States.
650 2 $aResearch$xStandards$zUnited States.
610 12 $aUnited States.$bFood and Drug Administration.
700 1 $aVernon, John M.$q(John Mitcham),$d1937-